-
A ruptured ectopic pregnancy is the leading cause of maternal mortality in the first trimester and accounts for 10 to 15% of all maternal deaths.
-
After two pretreatment cycles, 196 patients with menorrhagia were randomized to tranexamic acid or placebo.
-
Recent investigation into the molecular pathogenesis of epithelial ovarian cancer has implicated two dominant phenotypes.
-
When the Ortho Evra transdermal contraceptive (Ortho Women's Health & Urology, Raritan, NJ) was introduced in 2002, use of the patch caught on quickly with young women.
-
You have just reviewed instructions on proper oral contraceptive (OC) use with your patient, a 22-year-old mother of three.
-
[Editor's note: This story discusses off-label use of the antidepressant medication escitalopram (Lexapro, Forest Laboratories, New York City).]
-
A 25-year-old G3P1021 presents to clinic concerned that her intrauterine device (IUD) strings feel longer. She is otherwise asymptomatic.
-
HPV infection is a major cause of morbidity in both genders. HPV vaccination (both bivalent and quadrivalent) has proved effective in girls and women, including those outside of the original age indications and those with prior sexual activity. Much less is known of vaccine efficacy in boys and men for the prevention of HPV-associated diseases.
-
In this issue: Apixaban and rivaroxaban near approval for nonvalvular atrial fibrillation; fidaxomicin for C. difficile infections; guideline for intensive insulin therapy; and FDA Actions.
-
After two pretreatment cycles, 196 patients with menorrhagia were randomized to tranexamic acid or placebo.
